HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver TransplantationQiang Zhao, Xiaoshun He, Zhiyong Guo et al.|Clinical Cancer Research|2025Cited by 5
Figure 4 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver TransplantationQiang Zhao, Xiaoshun He, Jinbo Huang et al.|Unknown|2025Cited by 0
Supplementary Data1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver TransplantationQiang Zhao, Xiaoshun He, Zhiyong Guo et al.|Unknown|2025Cited by 0
Data from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver TransplantationQiang Zhao, Xiaoshun He, Jinbo Huang et al.|Unknown|2025Cited by 0
Figure 1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver TransplantationQiang Zhao, Xiaoshun He, Jinbo Huang et al.|Unknown|2025Cited by 0